1378872-36-6
中文名称
(2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide
英文名称
(2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide
CAS
1378872-36-6
分子式
C13H10Cl3N3O2
分子量
346.6
MOL 文件
1378872-36-6.mol
更新日期
2026/01/15 08:53:04
1378872-36-6 结构式
基本信息
中文别名
化合物ML239(E)-N'-((1H-吡咯-2-基)亚甲基)-2-(2,4,6-三氯苯氧基)乙酰肼
英文别名
ML239CID49843203
CID 49843203
CID-49843203
CID-49843203
ML 239
NVEDPFICKAIHKD-NGYBGAFCSA-N
CID-49843203
CID 49843203
CID49843203
ML-239
ML 239
ML239
1378872-36-6
(2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide
N'-[(E)-1H-Pyrrol-2-ylmethylene]-2-(2,4,6-trichlorophenoxy)acetoh ydrazide
(E)-N'-((1H-pyrrol-2-yl)methylene)-2-(2,4,6-trichlorophenoxy)acetohydrazide
物理化学性质
密度1.50±0.1 g/cm3(Predicted)
储存条件Inert atmosphere,2-8°C
溶解度在DMSO中的溶解度为15mg/mL（澄清溶液）
酸度系数(pKa)11.95±0.46(Predicted)
形态粉末
颜色白色至米色
稳定性DMSO、DMF或乙醇中的溶液可在-20°下稳定储存3个月。
InChI1S/C13H10Cl3N3O2/c14-8-4-10(15)13(11(16)5-8)21-7-12(20)19-18-6-9-2-1-3-17-9/h1-6,17H,7H2,(H,19,20)/b18-6+
InChIKeyNVEDPFICKAIHKD-NGYBGAFCSA-N
SMILESClc1cc(Cl)c(OCC(=O)N\N=C\c2ccc[nH]2)c(Cl)c1
安全数据
警示词警告
危险品标志Xn
危险类别码20/21/22-36/37/38
安全说明26
危险品运输编号UN 3077 9 / PGIII
WGK Germany3
存储类别11 - Combustible Solids
危险性类别Acute Tox. 4 Dermal
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Aquatic Acute 1
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
Acute Tox. 4 Inhalation
Acute Tox. 4 Oral
Aquatic Acute 1
Eye Irrit. 2
Skin Irrit. 2
STOT SE 3
ML239价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-19971 | (2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide ML239 | 1378872-36-6 | 5mg | 550元 |
| 2025/12/22 | HY-19971 | (2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide ML239 | 1378872-36-6 | 10mM * 1mLin DMSO | 620元 |
| 2025/12/22 | HY-19971 | (2,4,6-Trichloro-phenoxy)-acetic acid (1H-pyrrol-2-ylmethylene)-hydrazide ML239 | 1378872-36-6 | 10mg | 900元 |
常见问题列表
生物活性
ML239 是一种有效的选择性的乳腺癌肿瘤干细胞抑制剂，C50 值为 1.16 μM。体外研究
ML239 (Compound 7j) is a potent and selective inhibitor of breast cancer stem cells, with an IC 50 of 1.16 μM, with ∼24-fold selectivity against the control cell line. ML239 inhibits breast cancer stem-like cells, most likely through activation of fatty acid desaturase 2 (FADS2). ML239 is cytotoxic to NCIH661 cells, and FADS2 knockdown reduces ML239 cytotoxicity, and furthermore, FADS2 inhibitor SC-26196 also reduces ML239 cytotoxicity in cancer cell lines (CCLs).